CEL-SCI (CVM) Files $10M Mixed Securities Shelf
More News related to CVM
- CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
- CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine
- Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big?
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- CEL-SCI Corp. (CVM) Reports on Work Conducted on LEAPS Vaccine Technology
More News related to Equity Offerings
- Xerox (XRX) Closes $2B Unsecured Senior Note Offering
- American Water Works (AWK) Closes $60M Debt Offering
- ZIOPHARM Oncology (ZIOP) Prices 15.5M Common and 7.74M Warrant Offering at $3.10/Unit
- Regency Centers (REG) Prices 8M Common Offering at $30.75/Share
- Western Gas (WES) Prices 6M Common Unit Offering at $18.20/Unit
CEL-SCI Corp. (NYSE: CVM) filed to offer up to $10 million in various securities. The company may offer from time to time shares of common stock, preferred stock, convertible preferred stock, promissory notes, convertible notes, rights, warrants, or securities issuable upon the exercise of warrants at an initial offering price not to exceed $10,000,000, at prices and on terms to be determined at or prior to the time of sale in light of market conditions at the time of sale.
Related Categories
Equity OfferingsStocks Mentioned
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
